دورية أكاديمية
Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus. Importancia de los títulos de anticuerpos antifosfolípidos no criterio entre pacientes con síndrome antifosfolípido primario y pacientes con lupus eritematoso sistémico
| العنوان: | Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus. Importancia de los títulos de anticuerpos antifosfolípidos no criterio entre pacientes con síndrome antifosfolípido primario y pacientes con lupus eritematoso sistémico |
|---|---|
| المؤلفون: | Urrego Callejas, Tomás, Hernández, Alejandro, Ruiz Giraldo, Sebastián, Frade Sosa, Beatriz, Vanegas García, Adriana L., Muñoz, Carlos H., Rua, Carlona, Duque Botero, Julieta, González, Luis A., Vásquez, Gloria, Gómez Puerta, José A. |
| المصدر: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
| بيانات النشر: | Elsevier |
| سنة النشر: | 2023 |
| المجموعة: | Dipòsit Digital de la Universitat de Barcelona |
| مصطلحات موضوعية: | Lupus, Trombosi, Thrombosis |
| الوصف: | There is an increasing interest in the study of non-criteria antiphospholipid antibodies (aPL) including antibodies targeting domain 1 of the B2 glycoprotein 1 (anti-D1 B2GP1) and antibodies anti phosphatidylserine/ prothrombin (PS/PT).Our aim was to analyze a panel of conventional and non-criteria aPL in a cohort of patients with systemic lupus erythematosus (SLE) and primary antiphospholipid syndrome (APS), to describe if there are differences in aPL titers among groups, to evaluate clinical associations including risk of recurrent events of novel aPL.Observational study that evaluated at baseline antibodies against anti-D1 B2GP1 and anti PS/PT. Anti-D1 B2GP1 antibodies were tested using a chemiluminescent immunoassay. IgG and IgM anti PS/PT, aCL and anti B2GP1 by ELISA techniques. Therefore, patients were followed in order to identify new thrombotic events.133 patients with SLE and 23 with primary APS patients were included. Main APS manifestations were DVT (27%), obstetric morbidity (22%) and arterial thrombosis (10.1%). IgM anti PS/PT antibodies levels were (20.6 - 127) vs 21.9 (11.2 - 39.2) U/ml, p<0.001 in primary APS vs SLE with APS, respectively. Anti-D1 B2GP1, IgG and IgM anti PS/PT were associated with thrombotic and non-thrombotic manifestations. During follow-up, IgG B2GP1 were related with a significant cumulative risk of thrombosis.We found significant differences in serum titers of non-criteria aPL among patients with primary APS vs SLE with APS. Whether non-criteria aPL antibodies titers are useful to differentiate patients with primary and secondary APS requires further analysis in other populations.Copyright © 2022. Published by Elsevier España, S.L.U. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | 6 p.; application/pdf |
| اللغة: | English |
| تدمد: | 2173-5743 |
| العلاقة: | Reproducció del document publicat a: https://doi.org/10.1016/j.reumae.2023.01.001Test; Reumatologia Clinica, 2023, vol. 19, num. 4, p. 197-203; https://doi.org/10.1016/j.reumae.2023.01.001Test; http://hdl.handle.net/2445/205786Test; 9353139 |
| الإتاحة: | https://doi.org/10.1016/j.reumae.2023.01.001Test http://hdl.handle.net/2445/205786Test |
| حقوق: | (c) Elsevier, 2023 ; info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.6BEC6FE3 |
| قاعدة البيانات: | BASE |
| تدمد: | 21735743 |
|---|